Prospective Research Rare Kidney Stones (ProRKS)
Status: | Recruiting |
---|---|
Conditions: | Other Indications, Nephrology, Nephrology, Nephrology |
Therapuetic Areas: | Nephrology / Urology, Other |
Healthy: | No |
Age Range: | Any |
Updated: | 10/20/2018 |
Start Date: | May 2016 |
End Date: | July 2024 |
Contact: | Barb Seide |
Email: | RareKidneyStones@mayo.edu |
Phone: | 800-270-4637 |
The purpose of this study is to determine the natural history of the hereditary forms of
nephrolithiasis and chronic kidney disease (CKD), primary hyperoxaluria (PH), cystinuria,
Dent disease and adenine phosphoribosyltransferase deficiency (APRTd) and acquired enteric
hyperoxaluria (EH). The investigator will measure blood and urinary markers of inflammation
and determine relationship to the disease course. Cross-comparisons among the disorders will
allow us to better evaluate mechanisms of renal dysfunction in these disorders.
nephrolithiasis and chronic kidney disease (CKD), primary hyperoxaluria (PH), cystinuria,
Dent disease and adenine phosphoribosyltransferase deficiency (APRTd) and acquired enteric
hyperoxaluria (EH). The investigator will measure blood and urinary markers of inflammation
and determine relationship to the disease course. Cross-comparisons among the disorders will
allow us to better evaluate mechanisms of renal dysfunction in these disorders.
Severe, hereditary forms of nephrolithiasis cause marked excretion of insoluble minerals
important in stone formation, including primary hyperoxaluria, cystinuria, Dent disease, and
adenine phosphoribosyltransferase deficiency (APRTd). Patients with these disorders
experience recurring stones from childhood and are at high risk for chronic kidney disease
caused by crystal nephropathy. Enteric hyperoxaluria is an acquired disease characterized by
hyperoxaluria and calcium oxalate crystal nephropathy associated with chronic kidney disease,
and in that respect similar to the inherited stone diseases. The investigators will collect
longitudinal data of individual patients in order to provide clues about potentially
modifiable factors that influence disease severity and identify factors leading to kidney
injury. the investigator will measure blood and urinary markers of inflammation and determine
relationship to the disease course. Cross-comparisons among the disorders will allow to
better evaluate mechanisms of renal dysfunction in these diseases.
important in stone formation, including primary hyperoxaluria, cystinuria, Dent disease, and
adenine phosphoribosyltransferase deficiency (APRTd). Patients with these disorders
experience recurring stones from childhood and are at high risk for chronic kidney disease
caused by crystal nephropathy. Enteric hyperoxaluria is an acquired disease characterized by
hyperoxaluria and calcium oxalate crystal nephropathy associated with chronic kidney disease,
and in that respect similar to the inherited stone diseases. The investigators will collect
longitudinal data of individual patients in order to provide clues about potentially
modifiable factors that influence disease severity and identify factors leading to kidney
injury. the investigator will measure blood and urinary markers of inflammation and determine
relationship to the disease course. Cross-comparisons among the disorders will allow to
better evaluate mechanisms of renal dysfunction in these diseases.
Inclusion Criteria:
1. Diagnosis of primary hyperoxaluria
2. Diagnosis of enteric hyperoxaluria
3. Diagnosis of Dent Disease
4. Diagnosis of Cystinuria
5. Diagnosis of adenine phosphoribosyltransferase deficiency (APRTd)
6. Diagnosis of Lowe Syndrome
7. Diagnosis of Dent Disease Carrier
Exclusion Criteria:
1. Prior renal failure
2. History of liver and/or kidney transplant.
We found this trial at
9
sites
70 Washington Square S
New York, New York 10012
New York, New York 10012
(212) 998-1212
Principal Investigator: David Goldfarb, MD
Phone: 216-686-7500
New York University More than 175 years ago, Albert Gallatin, the distinguished statesman who served...
Click here to add this to my saved trials
1720 2nd Ave S
Birmingham, Alabama 35233
Birmingham, Alabama 35233
(205) 934-4011
Principal Investigator: Dean Assimos, MD
Phone: 205-996-2613
University of Alabama at Birmingham The University of Alabama at Birmingham (UAB) traces its roots...
Click here to add this to my saved trials
South 34th Street
Philadelphia, Pennsylvania 19104
Philadelphia, Pennsylvania 19104
215-590-1000
Principal Investigator: Lawrence Copelovitch, MD
Phone: 267-425-3937
Children's Hospital of Philadelphia Since its start in 1855 as the nation's first hospital devoted...
Click here to add this to my saved trials
300 Longwood Avenue
Boston, Massachusetts 02115
Boston, Massachusetts 02115
Principal Investigator: Michelle Baum, MD
Phone: 617-355-6129
Click here to add this to my saved trials
Click here to add this to my saved trials
3333 Burnet Avenue
Cincinnati, Ohio 45229
Cincinnati, Ohio 45229
Principal Investigator: Prasad Decarajan, MD
Phone: 515-636-4200
Click here to add this to my saved trials
Jacksonville, Florida 32216
Principal Investigator: William Haley, MD
Phone: 904-953-3071
Click here to add this to my saved trials
Rochester, Minnesota 55905
Principal Investigator: Dawn Milliner, MD
Phone: 800-270-4637
Click here to add this to my saved trials
555 University Avenue
Toronto, Ontario M5G 1X8
Toronto, Ontario M5G 1X8
Principal Investigator: Elizabeth Harvey, MD
Phone: 416-813-5082
Click here to add this to my saved trials